A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)
Clinical trial NCT03745820 · COMPLETED
Trial details
- NCT number
- NCT03745820
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-15
- Primary completion
- 2022-03-23
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.